Missing Blood Is Not a Negative Result: Reading Postmortem Methamphetamine Specimen Gaps

AI-assisted scientific editorial analysis. No personal review by Okorie Okorocha is claimed. This article explains how to read a published specimen dataset. It does not determine cause of death or interpret an individual case.

A postmortem toxicology summary may list blood, urine and several tissues without showing that every specimen was available in every case. That gap matters. A missing blood specimen is not a negative blood result. A tissue result is not automatically a substitute blood concentration. A comparison across specimens may involve different groups of cases.

A 2024 retrospective study by Alasmari and colleagues provides a useful example. The researchers examined methamphetamine and amphetamine findings in postmortem fluids and tissues, including cases with decomposition. The paper contains reporting inconsistencies, so its numerical comparisons require care. Its specimen tables nevertheless illustrate a basic reading task: establish what was actually available and measured before drawing an inference from the results. Full paper.

Start with the specimen, not the headline

The study concerns 27 postmortem cases from two regions of Saudi Arabia. Its Table 2 lists different numbers of cases for different specimens and analytes. Blood, urine, vitreous humor, liver, kidney, brain and stomach-wall tissue do not all have the same denominator. Results and Table 2, page 4.

That means a graph showing several specimen types should not be read as though every bar or box represents an identical set of people. The first questions are which cases contributed to each summary and whether the intended comparison requires measurements from the same case.

If blood is absent from a case record, label the gap precisely. Was blood unavailable at autopsy, collected but not submitted, submitted but not tested, unsuitable for analysis, or simply omitted from the documents provided? Those possibilities describe different limits. The report in hand may not resolve which occurred.

An honest working entry can say: “No blood result supplied; collection and testing status unresolved.” Replacing that with “blood negative” would invent a test result.

Keep availability separate from analytical detection

The study describes both unavailable specimens and situations in which amphetamine was not detected in a tested specimen despite findings in other specimens. These are distinct observations.

“Unavailable” concerns the material that could be examined. “Not detected” concerns an analytical result under a method's conditions. “Not reported” concerns the documents or reporting practice. A specimen inventory should preserve those distinctions rather than collapse them into an empty cell.

For each result, retain the named analyte, specimen source, unit, method and relevant reporting limit. If the reason for a blank entry is unknown, leave it unknown. Do not assign a zero concentration or infer that testing would have been negative.

This distinction is especially useful when reading a published table. The number of cases contributing to an amphetamine summary may differ from the number contributing to a methamphetamine summary. A reader needs the inclusion rule before interpreting that difference as a biological finding.

A paired ratio needs paired measurements

A tissue-to-blood ratio requires both measurements from the same case. The study's ratio tables therefore raise a different denominator question from its separate specimen summaries.

Suppose a report provides a tissue result but no blood measurement. A published tissue-to-blood median cannot supply the missing blood result. The group summary describes the cases in which the investigators could calculate the relationship. It does not measure the unknown value in another case.

This is also why dividing a median tissue concentration by a median blood concentration is not the same calculation as taking the median of individual paired ratios. The two operations use different information. A table of separate medians does not reveal how each person's tissue and blood measurements were paired.

Before using a published ratio, identify the paired-case count, the exact specimens, and the reason other cases were excluded. In this paper, some table labels and group counts are inconsistent. Those entries need clarification before precise numerical reuse. This article supplies no conversion factor.

Units identify what was measured

The paper reports fluid measurements per unit volume and solid-tissue measurements per unit mass. Keep those labels attached to the values. A tissue result in nanograms per gram and a blood result in nanograms per milliliter describe different specimens and denominators.

A higher numerical tissue value does not, by itself, identify what the circulating blood concentration was during life. Nor does it prove which specimen was the more accurate measure of an effect. The laboratory measured material collected after death, under particular collection and preparation conditions.

For broader context on sampling and postmortem change, see Postmortem Methamphetamine Redistribution: Why Sampling Site Changes the Result. The narrower issue here comes first: which measurements exist, and which comparisons can actually be made?

Decomposition groups are not before-and-after samples

The researchers compared cases classified as putrefied with cases classified as non-putrefied. That is a comparison between different cases. It is not a controlled experiment that measured the same specimen before and after decomposition.

The design therefore cannot isolate a universal decomposition effect from every other difference between cases. Specimen availability, postmortem interval, collection conditions, exposure history and other circumstances may differ. A group comparison does not automatically tell a reviewer how much a particular result changed.

The abstract broadly reports no significant concentration difference, while the detailed results and discussion address selected ratio differences. The discussion also gives conflicting directions for some liver and kidney comparisons relative to the results and figures. These are reasons to inspect the original passages and seek clarification, not to select the statement that best supports a preferred conclusion.

What additional specimens can and cannot add

Testing another available specimen can provide another observation. It may help evaluate an interpretation or reveal that an analyte was detectable in material other than the specimen first considered.

It does not erase the absence of a blood sample, establish an antemortem blood concentration, or independently resolve cause of death. The study itself emphasizes consideration of individual circumstances. Its small, uneven specimen subsets should not become universal rules for all decomposed remains.

A useful review file records each specimen's status, the result actually issued, the comparison being proposed and the evidence missing from that comparison. That structure makes a scientific disagreement easier to examine without manufacturing data to complete the picture.

Source and editorial disclosure

Alasmari A, Alhejaili A, Alharbi H, Alzahrani M, Zughaibi T. Challenges and insights: Methamphetamine analysis in post-mortem putrefied human tissues in a hot climate. Saudi Pharmaceutical Journal. 2024;32(3):101990. DOI. Full text.

This original AI-assisted explanation follows review of the full twelve-page paper. Tables and figures were inspected, and material reporting inconsistencies are retained as limitations. No individual case histories, source tables or figures are reproduced. The examples and review structure are editorial explanations, not a validated diagnostic method or a personal scientific opinion from Okorie Okorocha.